Background illustration for clinical trials search

Paid Clinical Trials Gainesville

Discover 648 paid clinical trials in Gainesville, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: Ocala FL, Maitland FL, Savannah GA, Boca Raton FL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase 3, Recruiting

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

for
Early Alzheimer's Disease
Location: Ocala FL, The Villages FL, Maitland FL, Winter Park FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 50 - 70+

Code: NCT07033494

Phase 2, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Ocala FL, Lake City FL, Fleming Island FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Ocala FL, Lake City FL, Ormond Beach FL, Winter Park FL,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT07082738

Phase 2, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Ocala FL, Jacksonville FL, Leesburg FL, Winter Park FL,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06878261

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Ocala FL, Jacksonville FL, Safety Harbor FL, Tampa FL,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Ocala FL, Jacksonville FL, Orange City FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06350097

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Ocala FL, Jacksonville FL, St. Petersburg FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Ocala FL, Lake City FL, Crystal River FL,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06283966

Phase 3, Recruiting

Rib Fixation for Clinically Severe Rib Fractures From Trauma

for
Rib Fracture, Flail Chest
Location: Ocala FL, Sanford FL, Fort Pierce FL, Miami FL,
Sponsor: Darwin Ang

Sex: All

Age: 18 - 70+

Code: NCT02595593

Recruiting

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

for
Obesity, Overweight, Chronic Weight Management,
Location: Ocala FL, Jacksonville FL, Leesburg FL, Ocoee FL,
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07654374

Phase 3, Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Ocala FL, Jacksonville FL, Orlando FL, Tampa FL,
Sponsor: Cytokinetics

Sex: All

Age: 18 - 70+

Code: NCT06736574

Phase 3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Ocala FL, The Villages FL, Jacksonville FL,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

for
Hidradenitis Suppurativa (HS)
Location: Ocala FL, Tampa FL, West Palm Beach FL, Boca Raton FL,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06855498

Phase 3, Recruiting

A Study of LM-24C5 For Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Ocala FL
Sponsor: LaNova Medicines Limited

Sex: All

Age: 18+

Code: NCT06187402

Phase 1, Phase 2, Recruiting

Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

for
Chemotherapy-induced Nausea and Vomiting
Location: Ocala FL, Lakeland FL, Savannah GA, Miami Lakes FL,
Sponsor: Xiamen LP Pharmaceutical Co., Ltd

Sex: All

Age: 18+

Code: NCT05199818

Phase 3, Recruiting

A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)

for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
Location: Ocala FL, Augusta GA, Birmingham AL, Winston-Salem NC,
Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 18+

Code: NCT06163430

Phase 1, Phase 2, Recruiting

Breast Cancer Liquid Biopsy Trial

for
Breast Cancer, Cancer
Location: Ocala FL, Orlando FL, Sarasota FL, Hollywood FL,
Sponsor: Anthony Magliocco

Sex: All

Age: 18+

Code: NCT04962529

Recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

for
Breast Neoplasms, Carcinoma, Ductal, Breast,
Location: Ocala FL, Jacksonville FL, Jupiter FL, Morgantown WV,
Sponsor: Natera, Inc.

Sex: All

Age: 18+

Code: NCT07214532

Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for
Carcinoma, Non-Small-Cell Lung
Location: Ocala FL, Jacksonville FL, Orange City FL, Tampa FL,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase 3, Recruiting